Compounded Medications Notice (GLP-1s and Others)
When compounded options are available, they are prepared under 503A and sold only pursuant to patient-specific prescriptions. Compounded medications are not reviewed or approved by the FDA and are not equivalent to FDA-approved drugs. Use is limited to cases where an FDA-approved alternative is unavailable or clinically inappropriate for an individual patient, as permitted by law.